Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer.
about
Cancer classification in the genomic era: five contemporary problemsAge-associated prognostic and predictive biomarkers in patients with breast cancer.Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patientsImpact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer.Age-specific changes in intrinsic breast cancer subtypes: a focus on older womenPAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.Expression of aryl hydrocarbon receptor in relation to p53 status and clinicopathological parameters in breast cancer.Biology of breast cancer in young women.Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays.Genomic aberrations in young and elderly breast cancer patients.Gene-expression signature functional annotation of breast cancer tumours in function of ageComparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only StudyPrognostic effect analysis of molecular subtype on young breast cancer patientsCorrelation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer PatientsAssociations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.Long-term outcome in young women with breast cancer: a population-based study.HER2-positive endometrial cancer subtype carries poor prognosis.Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China.Circulating microRNA biomarkers for glioma and predicting response to therapy.The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women.Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy.CX3CL1 expression is associated with poor outcome in breast cancer patients.Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco.Protein biomarkers for subtyping breast cancer and implications for future research.Oncological safety of nipple-sparing mastectomy in young patients with breast cancer compared with conventional mastectomy.A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response.Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
P2860
Q26781783-04A937DC-6A5E-491D-93A5-41C557BA1448Q33750880-5E27D269-541D-4A08-B331-1E8FC17A83CEQ33825677-708DF168-2AF5-4423-8E28-9BE1FFE3DA15Q34141851-AC1D2C1A-CE69-4977-A4C6-5C51F89150D0Q34359310-C4D96161-AB0F-4979-944F-9D979E329200Q34433549-25FF7DD7-157B-4767-83FE-3F3C1D7B6B83Q34732853-AA570A46-701B-4E6D-B5AA-58A55909DC19Q35000798-94A8A2F4-A7A0-41CC-9A61-F4B19DD0BD1AQ35170898-41BC0CE3-7FC1-40F6-A69C-6291D84369C5Q35807554-2EC64FFE-4760-4C26-96A9-837D92C51E20Q35849104-354E3000-D1BA-492E-A9A5-0CA04BB460A1Q35975033-4ABC9473-76C9-47F8-96BD-95A143741A7FQ36029962-E4A9D3C2-CC77-416A-A075-EC0C48A1792FQ36038013-A0BA2D27-D3A1-47F5-A400-9B7D9B79AF3DQ36235990-860A501C-8510-4D75-8F37-E23921F45941Q37310148-FD2EB63D-C01A-4D8C-A4BF-1795984FC8D8Q37700593-74400EBD-7A0A-48A3-8A5F-8B102926E3D5Q37738530-1A791E1C-DFD0-4BB9-8735-D3E1EB9DA2F3Q38201683-1D7951E3-2569-485E-94FA-3E7F2A9A7087Q38428822-A081F326-3F2E-4251-91CF-383C9564C80DQ41992457-C959FB2B-2FB7-45EC-B24C-6DBA41DC912FQ43501063-5D514235-0707-45A9-9CE4-20763C936D35Q46301419-522DBD20-6BAC-466F-987C-4D86682198F2Q47261659-0B186E51-B045-4666-81A2-E2591C950E66Q52355152-5210D4D7-29E8-4515-88B4-ADE237F35503Q52692110-B3936574-ABD9-4E19-BD47-04459C5B1CB0Q54323377-08D49E0D-240A-4BD8-96DB-3D688DD118B1
P2860
Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumour biomarker expression re ...... pes of invasive breast cancer.
@ast
Tumour biomarker expression re ...... pes of invasive breast cancer.
@en
type
label
Tumour biomarker expression re ...... pes of invasive breast cancer.
@ast
Tumour biomarker expression re ...... pes of invasive breast cancer.
@en
prefLabel
Tumour biomarker expression re ...... pes of invasive breast cancer.
@ast
Tumour biomarker expression re ...... pes of invasive breast cancer.
@en
P2093
P2860
P356
P1476
Tumour biomarker expression re ...... pes of invasive breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2012.219
P407
P577
2012-06-19T00:00:00Z